Ocugen OCGN
NASDAQ OCGN
$1.02 -0.07 (-6.25%)
As of: Sep 30, 2026 · 3:13 PM EDT

Ocugen (OCGN) Capital Leases (2018 - 2019)

Updated

Ocugen's Capital Leases came in at $17,339 for Q3 2019.

Analysis

Ocugen (OCGN) Capital Leases (2018 - 2019) Analysis & Trends

At the end of FY2018, Ocugen's Capital Leases was $33,720.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Ocugen 369.56 Mn 186.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 17,339.00
Dec 31, 2018 33,720.00
API Access

Ocugen Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=OCGN&period=max&api_key=YOUR_API_KEY